Nepal requests India's COVID-19 vaccines on priority; India approves

WION Web Team
New Delhi, Delhi, India Published: Jan 17, 2021, 09.13 PM(IST)

EAM Jaishankar with Nepalese counterpart Gyawali Photograph:( ANI )

Story highlights

This has come a day after Nepal approved emergency use of the Covidhield vaccine, developed by AstraZeneca and Oxford University

A day after India began the biggest coronavirus vaccine drive for locals, its neighbouring country, Nepal, has lauded the South Asian country as frontrunner.

Kathmandu, on Sunday, claimed India's vaccine drive has given the Oli government "great hope" and Nepal's Foreign Minister Pradeep Kumar Gyawali has requested India's vaccine for Nepal locals now.

Also read| First person to receive COVID-19 vaccine in India urges everyone to 'go for it'

"Today as we wait for the availability of COVID-19 vaccines, India is one of the frontrunners. This has given us great hope. I take this opportunity to congratulate India and its innovative companies for success. Being next door, we believe we too will be availing these vaccines," Gyawali said during an event of Indian Council of World Affairs.

India, through a press release, has accepted the request. "Nepal congratulated India on the remarkable success in the production of Covishield and Covaxin vaccines in India and requested for early provision of vaccines to Nepal," the release read.

Also read| Covid vaccine, border issue discussed during India-Nepal talks in Delhi

As per a report by an Indian media house, Hindustan Times, the Indian government has they will be provided with these vaccines on priority saying the "requirements of Nepal would be in priority consideration after the roll-out of vaccines."

It also claimed that the Indian government will be announcing the supply schedule of the vaccines in the coming week. This decision was, as per the report, conveyed to Gyawali during his recent India visit. 

This has come a day after Nepal approved emergency use of the Covishield vaccine, developed by AstraZeneca and Oxford University and manufactured by the Serum Institute of India (SII).

Read in App